These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10934521)

  • 21. Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection.
    Caughey B; Race RE
    Ann N Y Acad Sci; 1994 Jun; 724():290-5. PubMed ID: 8030949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform.
    Vorberg I; Groschup MH; Pfaff E; Priola SA
    J Virol; 2003 Feb; 77(3):2003-9. PubMed ID: 12525634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of scrapie strain glycoform variation.
    Vorberg I; Priola SA
    J Biol Chem; 2002 Sep; 277(39):36775-81. PubMed ID: 12138171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of the disulfide bond in prion protein conversion.
    Herrmann LM; Caughey B
    Neuroreport; 1998 Aug; 9(11):2457-61. PubMed ID: 9721914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
    Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
    J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):399-404. PubMed ID: 7913757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation.
    Demaimay R; Harper J; Gordon H; Weaver D; Chesebro B; Caughey B
    J Neurochem; 1998 Dec; 71(6):2534-41. PubMed ID: 9832153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain.
    Horiuchi M; Baron GS; Xiong LW; Caughey B
    J Biol Chem; 2001 May; 276(18):15489-97. PubMed ID: 11279046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy.
    Jeffrey M; McGovern G; Goodsir CM; Brown KL; Bruce ME
    J Pathol; 2000 Jul; 191(3):323-32. PubMed ID: 10878556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.
    Moore RA; Herzog C; Errett J; Kocisko DA; Arnold KM; Hayes SF; Priola SA
    Protein Sci; 2006 Mar; 15(3):609-19. PubMed ID: 16452616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells.
    Caughey B; Neary K; Buller R; Ernst D; Perry LL; Chesebro B; Race RE
    J Virol; 1990 Mar; 64(3):1093-101. PubMed ID: 1968104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal properties of prion protein with insertional mutations in different cell types.
    Priola SA; Chesebro B
    J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes.
    Baron GS; Wehrly K; Dorward DW; Chesebro B; Caughey B
    EMBO J; 2002 Mar; 21(5):1031-40. PubMed ID: 11867531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive.
    Caughey B; Raymond GJ
    J Biol Chem; 1991 Sep; 266(27):18217-23. PubMed ID: 1680859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells.
    Priola SA; Caughey B; Race RE; Chesebro B
    J Virol; 1994 Aug; 68(8):4873-8. PubMed ID: 7913509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scrapie associated PrP accumulation and its prevention: insights from cell culture.
    Caughey B
    Br Med Bull; 1993 Oct; 49(4):860-72. PubMed ID: 8137133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
    Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
    Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.